Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Peptonic Medical launches the VagiVital® webshop

Stockholm 9th July 2018 - Peptonic Medical AB (publ) (’Peptonic’) or (’Company’) today announced that VagiVital® now can be purchased via its webshop on www.vagivital.se . VagiVital® is Peptonic’s hormone-free self-care product for the treatment of symptoms associated with vaginal atrophy. The product has been tested in clinical studies with excellent results. The clinical studies have been carried out at Karolinska Hospital in Huddinge, Akademiska Universitetssjukhuset in Upsala and Norrlands Universitetssjukhus in Umeå, Sweden.   -          This is a historical event in Peptonic. Since

Brighter defines market vision for Actiste until 2023 on 5 continents.

Brighter AB (publ) has developed estimates of segment size and ideal target markets for the company's diabetes solution Actiste® Diabetes Management as a Service for 14 markets. "These 14 markets are examples of potential target markets for us to penetrate. We weighed in barriers to entry, the size of the market, healthcare structure and how fast diabetes is spreading in the region. Seven of the 14 countries are featured on the International Diabetes Federation (IDF) list of the worlds top10 countries with the highest number of people diagnosed with diabetes, and 6 of them are expected

D. Carnegie & Co invites to an audiocast in connection with publication of the second quarterly report 2018

D. Carnegie & Co AB (publ) – listed on Nasdaq Stockholm – invites to an audiocast at 10.00 am on 13 July in connection with the publication of its second quarterly report 2018, which will be published that day at 7.00 am.Shareholders, analysts and other interested parties are welcome to participate in an audiocast in which the financial report for the second quarter will be presented by CEO Svein Erik Lilleland and CFO Jonas Andersson. The presentation and related material will be accessible through http://www.dcarnegiegroup.se/en/ and can be followed via web or by telephone on the numbers

TargetEveryOne AB (publ) - Stabilization notice

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.TargetEveryOne AB (publ) - End of stabilization and exercise of over-allotment optionJuly 9, 2018: Reference is made to the press release issued on June 8, 2018 regarding potential stabilization activities on Merkur Market in respect of the shares in TargetEveryOne AB (publ) (the "Company" or "TargetEveryOne", ticker: TEONE-ME) in the period from

Stillfront Group AB: MAU grew by 26% YoY

PRESS RELEASEJuly 9, 2018 MAU grew by 26% YoY Stillfront Group AB ("Stillfront") systematically works with improving the product portfolio to optimize performance and reward/risk. Among many things, Stillfront continuously monitors the number of active users of the online games on a monthly basis (MAU - Monthly Active User) and daily basis (DAU - Daily Active User). During the second quarter of 2018, the average number of MAUs was 4,237,000. The number of DAUs was 1,021,000 on average during the quarter. The corresponding figures for the second quarter of 2017 were 3,354,000 and

Obducat receives order for a MC 204 system from MicroOLED

OBDUCAT AB (publ) subsidiary Obducat Europe GmbH, a leading supplier of system solutions for lithography processing, has received an order from a leading AMOLED manufacturer, for the supply of a MC 204 (fully automated resist coating and developing system). The order value amounts to approx. 390.000 Euro.The MC 204 system will be installed in the customers cleanroom production facilities in Grenoble, France. The customer target with the investment is to bring their production facilities to higher automation level as well as to increase production capacity. The MC 204 system is planned to

EQT acquires Saxo Payments Banking Circle

· EQT VIII and EQT Ventures, in partnership with Saxo Payments Banking Circle’s founders and other co-investors, to acquire Saxo Payments Banking Circle · Saxo Payments Banking Circle’s unique banking platform enables cross-border payments with reduced complexity, time and cost · EQT to support Saxo Payments Banking Circle’s continued growth by leveraging the entire EQT platform, including around 25 years of experience in future-proofing companies as well as accelerating hyper-growth businesses, deep TMT expertise, and a global industrial network The EQT VIII fund (“EQT VIII”)

Invitation to presentation of Inwido´s interim report on July 16

Inwido, Europe’s largest supplier of windows and a leading door supplier, will publish its second quarter results on July 16, 2018 at 07:45 am CET.A conference call for investors, analysts and media will be held at 10.00 (CET) that same day. The report will be presented by Håkan Jeppsson, President and CEO and Peter Welin, CFO. The presentation will be held in English and will also be live webcasted at; http://www.inwido.com/investors/financial-reports-and-presentations. Here you will also find the presentation material for the meeting before it starts. It will also be possible to take

Handelsbanken’s interim report for January-June 2018 will be presented on July 18

Handelsbanken will present its results for January­‑June 2018 in Stockholm on July 18, 2018, at 8:00 a.m. CET, at a meeting with the media and analysts. The interim report for January‑June 2018 will be published at 6:30 a.m. CET, on July 18, 2018.A telephone conference will be held at 10:30 a.m. CET (4:30 a.m. EST), when Rolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 203–364 5374Swedish number: +46 8–505 564 74US number: +1 855–753 2230 Instructions1. Dial +xx xxx xx 10 minutes before

Construction start and acquisitions drive activity in Gårda

·  Rental income increased to SEK 513 million (497)  ·  Income from property management amounted to SEK 251 million (249)  ·  Profit for the period amounted to SEK 649 million (432)  ·  The value of properties rose to 16,118 million (SEK 15,559)  ·  Long-term net asset value (EPRA NAV) per share was SEK 62.85 (58.39)   ·  Earnings per share amounted to SEK 5.40 (3.60)  ·  Construction start on the Gårda Vesta project, which will be the highest office building in Gothenburg  ·  Disposal of the Älvsborg 178:9 office property in Långedrag  ·  After the end of the

Kungsleden strengthens within business development

Kungsleden develops and strengthens its organization by setting up a Business Development department headed by Frida Stannow Lind. In her new role as Head of Business Development, Frida will work in close cooperation with the CEO and the Head of Real Estate’s to maximize the profitability of properties and projects, as well as to identify, develop and implement new services and products demanded by tenants.The Business Development department’s responsibilities include management, coordination and development of activities related to leasing, property development and technical activities

REPURCHASED SHARES IN KARO PHARMA DURING WEEK 27 2018

During the period 2 July 2018 to 6 July 2018, Karo Pharma AB (publ) (LEI code 213800G54Z51LOPGTA79) has repurchased in total 365,224 own shares (ISIN: SE00007464888). The repurchases form part of the SEK 86.3 million share repurchase programme that Karo Pharma announced on 18 June 2018. The share repurchase programme, which runs between 18 June 2018 and 31 August 2018, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052.During the period 2 July 2018 – 6 July 2018, shares in Karo Pharma have

Hansa Medical lead candidate imlifidase (IdeS) granted orphan drug designation by the FDA for anti-GBM antibody disease

Hansa Medical today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to imlifidase (IdeS) for the treatment of anti-GBM antibody disease (anti-GBM), also known as Goodpastures disease. More information about the orphan drug designation has been posted on www.fda.govAnti-GBM is a severe kidney disease where the immune system mistakenly develops IgG-antibodies, resulting in an acute immune attack on the kidneys and in some patients also on the lungs. In severe anti-GBM, the disease may progress to renal failure or death. There is no approved

Tor Einar Norbakk, appointed new CEO of Svenska Aerogel - Continued focus on production and global expansion

Tor Einar Norbakk - currently Sandvik Mining & Rock Technology – has been appointed new CEO of Nasdaq First North-listed Svenska Aerogel. He will succeed Anders Lundström who choses to leave the assignment as CEO after 8 years. Tor Einar Norbakk will focus on building production and continuing global expansion. Tor Einar Norbakk will assume his new position on January 7, 2019.- First of all, I would like to thank Anders Lundström for his important role in the construction of Svenska Aerogel and regret that he leaves. At the same time, we welcome Tor Einar Norbakk, who has a very good

Hans Vestberg will resign as Vice Chairman of Hexagon’s Board

Due to Hans Vestberg’s new position as CEO of Verizon Communications Inc., Hans has announced that he will leave Hexagon AB’s Board as of 1 August 2018. The Nomination Committee will propose a successor in conjunction with the notice of the Annual General Meeting 2019. Hans Vestberg has been Vice Chairman of the Board since 2017. For further information, please contact: Maria Luthström, Investor Relations Manager, Hexagon AB, +46 8 601 26 27, ir@hexagon.com Kristin Christensen , Chief Marketing Officer, Hexagon AB, +1 404 554 0972, media@

Marco Lucisano new head of RISE Bioeconomy

RISE appoints Marco Lucisano as new head of the division Bioeconomy. Marco Lucisano will take office on August 1, 2018.In the future circular bioeconomy, forest-based renewable products can replace many of today's fossil-based. RISE is an important player in this direction through the division Bioeconomy. Our role as an innovation partner spans from regional to international cooperation to solve the industry's current and future challenges. The Bioeconomy division works across the entire chain from raw materials to finished bio-based materials, chemicals and fuels. The division's pilot

Interim Report January-June 2018

The second quarter of the year has been eventful. Magnolia Bostad’s shares have been listed on Nasdaq Stockholm's main list, we have started collaborating with several new partners and implemented a number of acquisitions and sales.January-June 2018 · Net sales amounted to SEK 798 m (869). · The operating profit was SEK 206 m (147). · Net profit for the period was SEK 139 m (99). Earnings per share, after deductions for minority shares was SEK 3.60 per share (1.63). · Over the period Magnolia Bostad agreed on the acquisition of 2,511 estimated building rights (5,825) and the

SBB continues its expansion in Norway through an acquisition of two elderly care homes

Samhällsbyggnadsbolaget in Norden AB (publ) ("SBB") expands its community service property portfolio in the Nordic metropolitan regions through the purchase of two elderly care homes in Tønsberg in the Oslo region. The properties have a total leasable area of 5,846 square meters with an estimated annual operating net income of approximately SEK 11.8 million (approximately SEK 12.9 million). The properties are fully let to Attendo, with recently renewed 5-year leases. SBB is already Norway's leading player in the community service property sector and this is the company’s first step into

TC TECH delivers the first unit of its upgraded production system to Taiwan

TC TECH Sweden AB (publ) announces that the company is delivering an upgraded production system for volume production of LGPs for displays to a Taiwanese customer after successfully completed tests in the company’s facilities in Stockholm. The installation in Taiwan is expected to be completed in July.The upgraded production system will replace a previously delivered system, as communicated in the press release published on February 7, 2018. The tests of the upgraded production system were conducted on behalf of the client in TC TECHs cleanroom in the company’s facilities in Stockholm.

YIT has signed an agreement with Boliden on the expansion of a water basin in Gällivare, Nothern Sweden

YIT CORPORATION Press release July 9, 2018, at 9 a.m.YIT and Boliden have signed an agreement on the expansion of a water basin to ensure future operation of a copper mine in Gällivare, Aitik, in Northern Sweden. The construction work is scheduled to begin in May 2018 and will be completed in November 2020. The parties have agreed that the transaction value will not be published. Under 3 years, YIT will build basins for water processing and move about 5 million m3 of soil and rock material. The project includes large mass displacement in a short period of time and dam construction

Invent medic’s TVS approved for CE marking

Invent medic Sweden AB ("invent medic") hereby announces that the company has received the CE marking approval for its medical device, which means that the product is now approved for sale on the European market.  The TVS is scheduled to be launched in Sweden after the summer of 2018."It is a great feeling that we have received an approved CE marking of our product, TVS. We continue our work in preparation for the market launch planned for after the summer of 2018. I look forward with great confidence to launching the TVS that can be of great help to the large number of women who today feel

NEXT Biometrics Selects Former IDEMIA Executive Alain Faburel To Lead Global Sales and Marketing Organization

New Sales Structure Created to Better Serve Customers GloballyOSLO, June 9, 2018 -- NEXT Biometrics (Oslo Bors: NEXT), a global leader in fingerprint sensor technology, today announced former IDEMIA Executive Alain Faburel has joined the company as chief sales and marketing officer. In addition to his history leading innovative and successful sales and marketing organizations, Faburel joins NEXT Biometrics with extensive experience in smart card and digital security technologies. Highlights of his background include nine years (1999 to 2008) with Gemalto, culminating in his role as

Interim report Jan-Jun 2018: Continued strong growth for Wihlborgs

· Rental income rose 20 percent to SEK 1,330 million (1,106) · Operating surplus rose 18 percent to SEK 957 million (810) · Income from property management rose 23 percent to SEK 679 million (551) · Profit for the period totalled SEK 923 million (892), corresponding to earnings per share of SEK 6.00 (5.80)“As Wihlborgs’ new CEO, I am delighted to summarise a very strong quarter for the company, one in which our excellent growth has continued. Thanks to a region experiencing strong expansion, an attractive offering and dedicated employees, we can report very favourable net lettings

Share buy-backs in Telia Company during week 27 2018

During the period July 2, 2018, until July 6, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 1 650 000  own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on 20 April, 2018. The share buy-back programme, which runs between 23 April, 2018, and 22 March, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”).During the period July 2,

There are no items matching the current filter
There are no more items matching the current filter
Back to top